We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$710M
AUM Growth
-$45.7M
Cap. Flow
-$39.7M
Cap. Flow %
-5.59%
Top 10 Hldgs %
9.53%
Holding
2,469
New
584
Increased
596
Reduced
458
Closed
638

Sector Composition

Rank Sector Weight
1 Technology 11.11%
2 Energy 9.76%
3 Consumer Discretionary 8.51%
4 Industrials 8.43%
5 Healthcare 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBGI icon
201
Sinclair Inc
SBGI
$1B
$866K 0.12%
33,200
+16,700
+101% +$512K
CELG
202
DELISTED
Celgene Corp
CELG
$862K 0.12%
9,096
+1,054
+13% +$95.1K
SWBI icon
203
Smith & Wesson
SWBI
$660M
$850K 0.12%
+117,090
New +$1.09M
NRG icon
204
NRG Energy
NRG
$29.2B
$849K 0.12%
27,842
+2,031
+8% +$63.4K
ESRX
205
DELISTED
Express Scripts Holding Company
ESRX
$848K 0.12%
12,000
+300
+3% +$21.4K
ELV icon
206
Elevance Health
ELV
$83B
$847K 0.12%
7,083
+4,808
+211% +$551K
AT
207
DELISTED
Atlantic Power Corporation
AT
$845K 0.12%
+355,000
New +$1.28M
PFE icon
208
Pfizer
PFE
$145B
$844K 0.12%
30,066
-8,461
-22% -$237K
STNG icon
209
Scorpio Tankers
STNG
$3.89B
$840K 0.12%
10,107
-17,189
-63% -$1.62M
EBAY icon
210
eBay
EBAY
$47.6B
$836K 0.12%
35,072
-11,697
-25% -$260K
FTK icon
211
CALL
Flotek Industries
FTK
$968M
$832K 0.12%
5,317
+3,284
+162% +$562K
SBRA icon
212
Sabra Healthcare REIT
SBRA
$5.2B
$827K 0.12%
34,000
+9,000
+36% +$250K
LYB icon
213
LyondellBasell Industries
LYB
$19.6B
$818K 0.12%
7,525
+61
+0.8% +$6.6K
UTHR icon
214
United Therapeutics
UTHR
$21.9B
$812K 0.11%
6,308
+674
+12% +$69.5K
QLIK
215
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$811K 0.11%
30,000
NTRI
216
DELISTED
NutriSystem, Inc.
NTRI
$805K 0.11%
52,365
+6,000
+13% +$99.6K
OPLK
217
DELISTED
OPLINK COMMUNICATIONS INC
OPLK
$805K 0.11%
47,830
+44,413
+1,300% +$812K
NFX
218
DELISTED
Newfield Exploration
NFX
$798K 0.11%
21,527
-1,341
-6% -$55.6K
ENTR
219
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$798K 0.11%
300,000
+245,000
+445% +$701K
FMS icon
220
PUT
Fresenius Medical Care
FMS
$13.6B
$790K 0.11%
+11,400
New +$393K
TTM
221
PUT
DELISTED
Tata Motors Limited
TTM
$787K 0.11%
+18,000
New +$787K
ETN icon
222
Eaton
ETN
$170B
$784K 0.11%
12,375
-3,325
-21% -$236K
FCE.A
223
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$782K 0.11%
40,000
+39,050
+4,111% +$781K
AHT
224
Ashford Hospitality Trust
AHT
$21M
$771K 0.11%
81
+22
+37% +$235K
DSX icon
225
Diana Shipping
DSX
$311M
$771K 0.11%
+123,366
New +$876K

Similar funds

Prelude Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Prelude Capital Management held 2,469 positions worth $710M, down 6% from $756M the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Prelude Capital Management withdrew a net $39.7M in Q3 2014, closing 638 positions and reducing 458 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $5.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.1% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in CONCUR TECHNOLOGIES INC worth $6.4M.

  • Prelude Capital Management's largest Q3 2014 buy was CONCUR TECHNOLOGIES INC: 50,447 shares worth $6.4M.
  • Prelude Capital Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014, an estimated $6.42M increase.
  • Prelude Capital Management's biggest Q3 2014 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $4.48M.
  • Prelude Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.64M.
  • Prelude Capital Management's ten largest holdings make up 9.5% of its $710M portfolio in Q3 2014.
  • Prelude Capital Management opened 584 new positions and closed 638 in Q3 2014.
  • Prelude Capital Management's portfolio value fell 6% quarter-over-quarter to $710M.

Based on Prelude Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.